Institute

Back to overview
Name

Dépt Microbiologie et Médecine Moléculaire Faculté de Médecine Université de Genève

Address Dépt Microbiologie et Médecine Moléculaire Faculté de Médecine Université de Genève
Rue Michel-Servet 1
1211
CH-Genève 4
Show all

Projects

Responsible applicant Institution of higher education Start End date Funding scheme

New strategies for the treatment of toxoplasma encephalitis in AIDS
Chang Hernan R. University of Geneva - GE 01.04.1989 31.03.1991 Project funding (Div. I-III)

Chemical genetic dissection of the Pseudomonas aeruginosa cell polarity network
Kirkpatrick Clare University of Geneva - GE 01.04.2015 28.02.2017 Marie Heim-Voegtlin grants

An integrated approach to elucidate the molecular mechanisms governing host cell invasion and egress by the Apicomplexa
Soldati-Favre Dominique University of Geneva - GE 01.04.2019 31.03.2023 Project funding (Div. I-III)

Interactions of Paramyxoviruses and host cells
Garcin Dominique University of Geneva - GE 01.04.2007 31.03.2010 Project funding (Div. I-III)

Nutrient signal transduction and control of quisecence in yeast
De Virgilio Claudio University of Geneva - GE 01.08.2007 31.07.2010 Project funding (Div. I-III)

RIG-I-like receptors (RLRs) sensing of viral infections, beyond discrimination between self and non-self.
Garcin Dominique University of Geneva - GE 01.10.2018 30.09.2022 Project funding (Div. I-III)

Structure-Function Relationship of the Guanylate Cyclase Signaling Platform in Apicomplexa
Soldati-Favre Dominique University of Geneva - GE 01.03.2021 28.02.2025 Sinergia

Actomyosin-based motility and organelles biogenesis in Apicomplexans
Soldati-Favre Dominique University of Geneva - GE 01.04.2013 31.03.2016 Project funding (Div. I-III)

Adaptation of Pseudomonas aeruginosa during respiratory tract colonization and infection in mechanically ventilated patients: in vitro and in situ studies
Van Delden Christian University of Geneva - GE 01.04.2005 31.03.2008 Project funding (Div. I-III)

A) Cytokines, Vitamin D3 and nitric oxide in Toxoplasma cyst for-mation and rupture B) Cytokines, Vitamin D3 and nitric oxide in human phagocyte activation and response to infection
Chang Hernan R. University of Geneva - GE 01.04.1991 31.03.1993 Project funding (Div. I-III)

Regulation of the atypical cell cycle of malaria parasites by cullin-based E3 ubiquitin ligases
Brochet Mathieu University of Geneva - GE 01.04.2019 31.03.2022 Project funding (Div. I-III)

Replication of Parainfluenza Viruses and Bunya Viruses
Kolakofsky Daniel University of Geneva - GE 01.04.1984 31.03.1986 Project funding (Div. I-III)

At the Interface between Cell Biology and Cellular Microbiology
Soldati-Favre Dominique University of Geneva - GE 01.05.2012 31.12.2012 Scientific Conferences

“The impact of mRNA 5’TL heterogeneity: what we can learn from the 53BP1 and EIF4E3 genes”
Curran Joseph University of Geneva - GE 01.10.2017 30.09.2022 Project funding (Div. I-III)

Infection & Immunity Training
Soldati-Favre Dominique University of Geneva - GE 01.09.2009 31.08.2014 ProDoc

1. Mechanisms of transcription activation in vivo 2. Analysis of the interaction between hepatitis B virus encoded X protein and host cell protein DDB1.
Strubin Michel University of Geneva - GE 01.06.2003 31.08.2006 Project funding (Div. I-III)

Directed search for host surface proteins as antiviral targets against SARS-CoV-2
Schmolke Mirco University of Geneva - GE 01.02.2021 31.01.2023 Special Call on Coronaviruses

Study of factors governing the invasive and replicative modes in Apicomplexa
Soldati-Favre Dominique University of Geneva - GE 01.04.2010 31.03.2013 Project funding (Div. I-III)

The elk-1 gene: A model for how alternative splicing in the 5'UTR can modulate translational reinitiation in mammalian cells.
Curran Joseph University of Geneva - GE 01.10.2012 30.09.2015 Project funding (Div. I-III)

Down regulation of MHC class II genes in autoimmune diseases
Siegrist Claire-Anne University of Geneva - GE 01.01.1990 31.12.1992 Ambizione

An integrated approach to elucidate the molecular mechanisms governing host cell invasion by the Apicomplexa
Soldati-Favre Dominique University of Geneva - GE 01.04.2016 31.03.2019 Project funding (Div. I-III)

Molecular Biology of the Class II Genes of the Major Histo- compatibility Complex (MHC)
Mach Bernard University of Geneva - GE 01.01.1984 31.12.1986 Project funding (Div. I-III)

RNA helicases in virulence expression in Staphylococcus aureus
Linder Patrick University of Geneva - GE 01.10.2013 30.09.2016 Project funding (Div. I-III)

Transcription-coupled DNA repair and apoptosis: roles and partners of the human XPG protein
Clarkson Stuart Gordon University of Geneva - GE 01.04.2003 30.09.2005 Project funding (Div. I-III)

Genetic and biochemical characterization of a ribosomal shunt.
Curran Joseph University of Geneva - GE 01.04.2000 31.03.2003 Project funding (Div. I-III)

Function and regulation of the universally conserved heat shock proteins
Georgopoulos Costa Panos University of Geneva - GE 01.10.2006 30.09.2007 Project funding (Div. I-III)

Biological mechanisms associated with failures of antimicro- bial therapy
Pechère Jean-Claude University of Geneva - GE 01.04.1988 31.03.1990 Project funding (Div. I-III)

BiOutils and TheScienceBreaker: bringing academic researchers closer to STEM educators
Linder Patrick University of Geneva - GE 01.03.2017 30.06.2019 Agora

TRIM5 and Innate Resistance to HIV-1
Luban Jeremy University of Geneva - GE 01.10.2009 30.09.2012 Project funding (Div. I-III)

Structure, expression and regulation of the glucagon and insulin genes
Philippe Jacques University of Geneva - GE 01.10.1988 31.12.1991 Project funding (Div. I-III)

The multiplication of Paramyxoviruses: genome replication and its uptake into virus particles
Roux Laurent University of Geneva - GE 01.04.2002 30.09.2005 Project funding (Div. I-III)

Regulation and dysregulation of MHC class II genes
Reith Walter University of Geneva - GE 01.01.2000 31.12.2004 Project funding (Div. I-III)

Helicase and NTP-driven nucleic acids motors: structure, function, mechanism and roles in human disease
Linder Patrick University of Geneva - GE 01.06.2009 30.11.2009 Scientific Conferences

An endogenous retroviral superantigen as candidate autoimmune- gene in type I diabetes
Conrad Bernard University of Geneva - GE 01.01.1998 30.09.2003 START

Visit to University of Geneva to investigate the importance of sphingolipids biosynthesis and salvage pathways in Toxoplasma
Soldati-Favre Dominique University of Geneva - GE 01.02.2018 30.04.2018 Scientific Exchanges

A: Quinolones-oxacillin synergism B: Quinolone transport through cytoplasmic membrane C: Campylobacter jejuni invasiveness
Pechère Jean-Claude University of Geneva - GE 01.04.1990 31.03.1992 Project funding (Div. I-III)

Functional organization of cloned eukaryotic tRNA genes
Clarkson Stuart Gordon University of Geneva - GE 01.04.1983 31.03.1985 Project funding (Div. I-III)

Le cycle de multiplication d’un Paramyxovirus: assemblage des différents constituants et production de particules virales
Roux Laurent University of Geneva - GE 01.10.2008 30.09.2011 Project funding (Div. I-III)

Developmental transcription in the obligate intracellular bacterium causing scrub typhus
Viollier Patrick University of Geneva - GE 01.12.2020 30.11.2023 SPIRIT

The sendai virus enveloppe: Study of their interactions and of their effects on the infected cell fate by expression of their DNA cloned genes.
Roux Laurent University of Geneva - GE 01.04.1985 31.03.1988 Project funding (Div. I-III)

Development of a reverse genetics system to study mumps virus genome expression
Curran Joseph University of Geneva - GE 01.04.1997 31.03.2000 Project funding (Div. I-III)

Cell cycle-regulated surface structures and mobile DNA in bacteria
Viollier Patrick University of Geneva - GE 01.10.2018 30.09.2022 Project funding (Div. I-III)

Glucagon gene expression and regulation / insulin and glucose- transporter genes regulation by glucagon-like peptide I / molecu-lar basis of the syndrome of familial hypergluconemia(Subs.SCORE
Philippe Jacques University of Geneva - GE 01.09.1991 30.09.1994 Ambizione

Arbeitstagungen der USGEB (Union Schweizerischer Gesellschaften für experimentelle Biologie)
Mach Bernard University of Berne - BE 01.04.1987 30.09.1993 Scientific Conferences

Research & Development: Parasitology/pharmacology and drug discovery projects for Medicines for Malaria Venture
Soldati-Favre Dominique University of Geneva - GE 01.01.2020 31.12.2020 Research semester

Replication and assembly of Sendai virus: construction of a viralvector allowing the analysis of the viral assembly functions by site directed mutagenesis
Roux Laurent University of Geneva - GE 01.04.1994 31.03.1999 Project funding (Div. I-III)

Functional analyses of a human DNA repair protein
Clarkson Stuart Gordon University of Geneva - GE 01.04.1993 31.03.1998 Project funding (Div. I-III)

Functional organization of cloned eukaryotic tRNA genes.
Clarkson Stuart Gordon University of Geneva - GE 01.04.1979 31.03.1981 Project funding (Div. I-III)

Genetic and biochemical characterization of human endogenous HERV-K18 superantigens
Conrad Bernard University of Geneva - GE 01.10.2002 31.03.2004 Project funding (Div. I-III)

Etude de l'organisation des gènes des immunoglobulines
Mach Bernard University of Geneva - GE 01.10.1975 30.09.1977 Project funding (Div. I-III)

Regulation and function of multidrug efflux systems in Pseudomo- nas aeruginosa
Köhler Thilo University of Geneva - GE 01.04.1997 31.03.1999 Project funding (Div. I-III)

Pol III transcription and the La protein
Clarkson Stuart Gordon University of Geneva - GE 01.04.1990 31.03.1993 Project funding (Div. I-III)

Long-term consequences of microbiota alterations for host physiology after acute respiratory infections in childhood
Schmolke Mirco University of Geneva - GE 01.10.2018 30.09.2022 Project funding (Div. I-III)

Ultrastructural and functional study of the biogenesis, positioning and discharge of the rhoptries in Toxoplasma gondii
Soldati-Favre Dominique University of Geneva - GE 01.07.2016 31.12.2019 Brazil

A. Molecular determinants of S. typhimurium required for survivaland growth within macrophages B. Outer membrane permeabilty of P. aeruginosa
Pechère Jean-Claude University of Geneva - GE 01.04.1994 31.03.1997 Project funding (Div. I-III)

Etude du contrôle génétique de la diversité des anticorps
Mach Bernard University of Geneva - GE 01.10.1977 30.09.1979 Project funding (Div. I-III)

Acquisition and regulation of virulence factors in Staphylococcus aureus
Linder Patrick University of Geneva - GE 01.10.2010 30.09.2013 Project funding (Div. I-III)

Mode of action of bacterial virulence factors and what they tell us about protein and lipid trafficking in the mammalian cells
van der Goot Gisou University of Geneva - GE 01.10.2003 30.09.2008 Project funding (Div. I-III)

Adaptation and persistence of Pseudomonas aeruginosa during colonization and infection of ventilated patients
Van Delden Christian University of Geneva - GE 01.05.2008 30.04.2011 Project funding (Div. I-III)

Identification of cis-elements and regulatory factors conferring virus- and Interferon-a responsiveness to HERV-K18 superantigens AND analysis of the assembly of regulatory and general factors .
Conrad Bernard University of Geneva - GE 01.04.2002 31.12.2002 Project funding (Div. I-III)

Paramyxovirus multiplication cycle: RNA synthesis processes and virus particle production
Roux Laurent University of Geneva - GE 01.10.2005 30.09.2008 Project funding (Div. I-III)

Getting to know microbes: Offering the tools to provide an accurate microbiology education
Linder Patrick University of Geneva - GE 01.02.2014 31.01.2017 Agora

HIV accessory proteins and the biology of the cell
Trono Didier EPF Lausanne - EPFL 01.04.2003 31.03.2008 Project funding (Div. I-III)

Replication of Parainfluenza Viruses.
Kolakofsky Daniel University of Geneva - GE 01.10.1979 31.03.1982 Project funding (Div. I-III)

Long-term persistent infection by RNA viruses: Study of an in vitro experimental model using Sendai virus
Roux Laurent University of Geneva - GE 01.04.1983 31.03.1985 Project funding (Div. I-III)

Functional genomics of sex determination and ovarian development in mice
Nef Serge University of Geneva - GE 01.04.2005 31.03.2008 Project funding (Div. I-III)

RNA helicases in Staphylococcus aureus - from phenotypes to mechanism
Linder Patrick University of Geneva - GE 01.10.2019 30.09.2020 Project funding (Div. I-III)

Fifth HLA and H-2 cloning workshop
Mach Bernard University of Geneva - GE 01.05.1986 31.10.1986 Scientific Conferences

Replication of Parainfluenza Viruses and Bunya Viruses
Kolakofsky Daniel University of Geneva - GE 01.04.1986 31.03.1989 Project funding (Div. I-III)

Analysis of the dendritic cell specific promotor of CIITA. (MHV-Beitrag)
Mühlethaler-Mottet Annick University of Geneva - GE 01.10.1998 30.06.2001 Marie Heim-Voegtlin grants

Viral and host factors modulating rhinovirus and enterovirus disease severity
Tapparel Vu Caroline University of Geneva - GE 01.04.2016 31.03.2019 Project funding (Div. I-III)

Comprehensive description of the Sendai virus replication pro- motors and localisation of the virion component assembly
Roux Laurent University of Geneva - GE 01.04.1999 31.03.2002 Project funding (Div. I-III)

Functional genome analysis in a genetically intractable system: an interdisciplinary proof-of-concept study
Viollier Patrick University of Geneva - GE 01.09.2012 30.11.2015 Sinergia

Molecular dissection of gliding motility and host cell invasion by the apicomplexa
Soldati-Favre Dominique University of Geneva - GE 01.04.2007 31.03.2010 Project funding (Div. I-III)

Attenuated recombinant Salmonella as a tool for investigating the immune response against a model antigen
Kok Menno University of Geneva - GE 01.12.1996 31.12.1999 Project funding (Div. I-III)

Adherence and invasion factors in Campylobacter jejuni and their possible role in immunoprophylaxis
Pechère Jean-Claude University of Geneva - GE 01.04.1987 31.03.1990 Project funding (Div. I-III)

Interactions of antibiotics with bacterial membranes
Pechère Jean-Claude University of Geneva - GE 01.04.1992 31.03.1994 Project funding (Div. I-III)

A human endogenous retroviral superantigen as candidate auto- immune gene in type I diabetes
Conrad Bernard University of Geneva - GE 01.04.1998 31.03.2001 Project funding (Div. I-III)

A comprehensive characterization of key organellar metabolic transporters in Apicomplexa to enter in the drug discovery pipeline
Soldati-Favre Dominique University of Geneva - GE 01.05.2021 30.04.2024 India

Studies on XPG, a DNA repair protein implicated in two human diseases
Clarkson Stuart Gordon University of Geneva - GE 01.04.1998 31.03.2003 Project funding (Div. I-III)

Replication of paramyxoviruses
Kolakofsky Daniel University of Geneva - GE 01.04.2002 31.03.2008 Project funding (Div. I-III)

Etudes sur les beta lactamases
Pechère Jean-Claude University of Geneva - GE 01.04.1984 31.03.1986 Project funding (Div. I-III)

Mechanisms by which paramyxovirus defective interfering par- ticles(DI)promote in vitro persistent infections and attempt to show DI virus relevance in human infection
Roux Laurent University of Geneva - GE 01.04.1988 31.03.1991 Project funding (Div. I-III)

The molecular basis of congenital afibriogenemia: mutations, phenotypic modifiers and gene therapy
Neerman-Arbez Marguerite University of Geneva - GE 01.03.2002 28.02.2006 SNSF Professorships

TRIM5 and Innate Resistance to HIV-1
Luban Jeremy University of Geneva - GE 01.10.2006 30.09.2009 Project funding (Div. I-III)

Replication of Parainfluenza Viruses and Rhabdoviruses
Kolakofsky Daniel University of Geneva - GE 01.04.1982 31.03.1984 Project funding (Div. I-III)

RIG-I sensing of viral infections: beyond discrimination between self and non-self RNAs.
Garcin Dominique University of Geneva - GE 01.10.2015 30.09.2018 Project funding (Div. I-III)

Cell cycle-regulated surface structures in bacteria
Viollier Patrick University of Geneva - GE 01.10.2015 30.09.2018 Project funding (Div. I-III)

Molecular Basis of Cell Polarity and Division Control in Caulobacter crescentus
Viollier Patrick University of Geneva - GE 01.10.2009 30.09.2012 Project funding (Div. I-III)

Part I: Dynamics of Histone Exchange and Epigenetic Modifications during Transcription in vivo Part II: Hijacking of the DDB1 Ubiquitin Ligase by the HBV X Protein: What Role during Infection and Associated Liver Cancer?
Strubin Michel University of Geneva - GE 01.10.2009 30.09.2013 Project funding (Div. I-III)

Molecular analysis of transcriptional regulation in yeast (subside START)
Strubin Michel University of Geneva - GE 01.06.1992 28.02.2001 START

Regulatory interplay of cell cycle transcription factors in compartmentalized Caulobacter cells
Viollier Patrick University of Geneva - GE 01.10.2012 30.09.2015 Project funding (Div. I-III)

Morphogenesis and production of a Paramyxovirus particles
Roux Laurent University of Geneva - GE 01.10.2011 31.12.2013 Project funding (Div. I-III)

DksA as a novel modulator of virulence in Pseudomonas aeruginosa
Van Delden Christian University of Geneva - GE 01.04.2002 31.03.2005 Project funding (Div. I-III)

Functional organization of cloned eukaryotic tRNA genes
Clarkson Stuart Gordon University of Geneva - GE 01.04.1985 31.03.1987 Project funding (Div. I-III)

The hepatitis B virus encoded HBx protein and its interaction with host cell protein DDB1: Implications for viral infection and the pathogenesis of liver cancer
Strubin Michel University of Geneva - GE 01.09.2006 30.09.2009 Project funding (Div. I-III)

Virulence Gene Expression in Pseudomonas aeruginosa in the Absence of LasR. (SCORE A)
Van Delden Christian University of Geneva - GE 01.08.1998 31.07.2003 Ambizione

Molecular analysis of transcriptional regulation in vivo
Strubin Michel University of Geneva - GE 01.06.1997 31.05.2003 Project funding (Div. I-III)

Gamma Irradiator for Research in Immunology, Infectious Diseases, Stem Cell Biology, and Neurobiology
Luban Jeremy University of Geneva - GE 01.12.2009 30.11.2010 R'EQUIP

Sendai paramyxovirus as a non-integrative RNA virus vector
Kolakofsky Daniel University of Geneva - GE 01.06.1996 31.10.2001 NRP 37 Somatic Gene Therapy

Non-Haemoglobin Degrading Plasmepsins: Drug Targets validation from Bench to Field
Soldati-Favre Dominique University of Geneva - GE 01.04.2015 31.07.2018 India

Pathogenesis of Human rhinoviruses in the context of multiple infection
Essaidi-Laziosi Manel University of Geneva - GE 01.03.2018 31.08.2018 Marie Heim-Voegtlin grants

Innate immune functions of immature neutrophils (band forms)
Drifte Geneviève University of Geneva - GE 01.07.2009 31.05.2012 MD-PhD fellowships (funded by SNSF)

Factors modulating rhinovirus and enterovirus pathogenicity
Tapparel Vu Caroline University of Geneva - GE 01.04.2019 31.03.2023 Project funding (Div. I-III)

The Smc5/6 complex as an antiviral restriction factor: how does it work and how does hepatitis B virus fight back?
Strubin Michel University of Geneva - GE 01.10.2017 30.09.2022 Project funding (Div. I-III)

Replication of Parainfluenza Viruses and Bunya Viruses
Kolakofsky Daniel University of Geneva - GE 01.04.1989 31.03.1992 Project funding (Div. I-III)

Role of hepatitis B virus X protein during viral infection and associated liver cancer
Strubin Michel University of Geneva - GE 01.10.2013 30.09.2017 Project funding (Div. I-III)

Uncoating and nuclear transport of the HIV preintegration complex
Trono Didier University of Geneva - GE 01.09.1997 30.09.2002 Project funding (Div. I-III)

The molecular basis of ligand recognition by RIG-I and viral escape strategies
Garcin Dominique University of Geneva - GE 01.04.2011 31.03.2015 Project funding (Div. I-III)

Mammalian Translation initiation and cellular Growth Control: (a). Translational Regulation of the Transcription Factor ELK-1. (b). Studies on Global Regulation. (c). Translational Profiling of Chromosome 21
Curran Joseph University of Geneva - GE 01.04.2007 30.11.2010 Project funding (Div. I-III)

Dissection of gliding motility and host cell invasion by the apicomplexan parasites
Soldati-Favre Dominique University of Geneva - GE 01.01.2004 31.03.2007 Project funding (Div. I-III)

Molecular Biology of the Immune Response.
Mach Bernard University of Geneva - GE 01.10.1979 30.09.1981 Project funding (Div. I-III)

HIV nef and the biology of the cell
Trono Didier University of Geneva - GE 01.10.1997 31.03.2003 Project funding (Div. I-III)

Réplication et pathogenése des rhinovirus humains dans le contexte de co-infections avec d’autres virus respiratoires
Essaidi-Laziosi Manel University of Geneva - GE 01.11.2015 28.02.2018 Marie Heim-Voegtlin grants

Virulence Gene Expression in Pseudomonas aeruginosa in the Absence of LasR.(zu SCORE A)
Van Delden Christian University of Geneva - GE 01.08.1998 31.03.2002 Project funding (Div. I-III)

Replication of paramyxo- and arenaviruses
Kolakofsky Daniel University of Geneva - GE 01.04.1992 31.03.1997 Project funding (Div. I-III)

DEAD-box RNA helicases orchestrate translation initiation in bacteria and eukaryotes
Linder Patrick University of Geneva - GE 01.10.2007 30.09.2010 Project funding (Div. I-III)

Regulation and disregulation of MHC class II genes
Mach Bernard University of Geneva - GE 01.01.1995 31.12.1999 Project funding (Div. I-III)

Molecular analysis of transcriptional regulation in yeast
Strubin Michel University of Geneva - GE 01.10.1992 31.05.1997 Project funding (Div. I-III)

Replication of paramyxoviruses
Kolakofsky Daniel University of Geneva - GE 01.04.1997 31.03.2002 Project funding (Div. I-III)

Mechanisms involved in the pathogenesis of insulin-dependent diabetes mellitus
Conrad Bernard University of Geneva - GE 01.10.1994 31.03.1998 Project funding (Div. I-III)

Functional and biochemical characterization of the human endo- genous retroviral superantigen IDDMK22, a candidate autoimmune gene in type 1 diabetes
Conrad Bernard University of Geneva - GE 01.04.2001 30.09.2002 Project funding (Div. I-III)

Subside de perfectionnement: Médecine clinique
Philippe Jacques University of Geneva - GE 01.09.1988 31.08.1991 Ambizione

Pangenomic and comprehensive analysis of the relationship between bacterial toxin-antitoxin systems and antibiotic phenotype
Viollier Patrick University of Geneva - GE 01.12.2015 30.11.2019 Sinergia

Molecular biology of the class II genes of the major histo- compatibility complex (MHC) of man
Mach Bernard University of Geneva - GE 01.01.1990 31.12.1994 Project funding (Div. I-III)

Construction of mouse models and regulatory systems designed to optimise the control of transgene expression
Reith Walter University of Geneva - GE 01.11.1996 31.10.1999 NRP 37 Somatic Gene Therapy

Genetic and biochemical characterization of a ribosomal shunt.
Curran Joseph University of Geneva - GE 01.04.2003 31.03.2007 Project funding (Div. I-III)

Interaction of Influenza A virus with pathogenic and commensal bacteria
Schmolke Mirco University of Geneva - GE 01.10.2014 30.09.2018 Project funding (Div. I-III)

Long term persistent infection by RNA viruses: study of an in vitro experimental model
Roux Laurent University of Geneva - GE 01.04.1980 31.03.1983 Project funding (Div. I-III)

Regulation of the cGMP/Ca2+ signalling module in malaria parasites
Brochet Mathieu University of Geneva - GE 01.08.2015 31.07.2020 SNSF Starting Grants

Biological properties of bacterial surface proteins
Pechère Jean-Claude University of Geneva - GE 01.04.1986 31.03.1988 Project funding (Div. I-III)

RNA metabolism in virulence expression in Staphylococcus aureus
Linder Patrick University of Geneva - GE 01.10.2016 30.09.2019 Project funding (Div. I-III)

Molecular biology of the class II genes of the major histo- compatibility complex (MHC) of man
Mach Bernard University of Geneva - GE 01.01.1987 31.12.1989 Project funding (Div. I-III)

Functional organization of cloned eukaryotic tRNA genes
Clarkson Stuart Gordon University of Geneva - GE 01.04.1981 31.03.1983 Project funding (Div. I-III)

Regulation and deregulation of MHC class II genes
Reith Walter University of Geneva - GE 01.01.2005 31.12.2009 Project funding (Div. I-III)

Eukaryotic tRNA genes and their expression
Clarkson Stuart Gordon University of Geneva - GE 01.04.1987 31.03.1990 Project funding (Div. I-III)

Molecular exploration of the immediate early phase of HIV infection
Trono Didier University of Geneva - GE 01.10.2002 31.12.2005 Project funding (special)

RNA helicases in translation initiation and ribosome biogenesis
Linder Patrick University of Geneva - GE 01.10.2004 30.09.2007 Project funding (Div. I-III)

RNA-binding proteins as multifaceted regulators of Pseudomonas aeruginosa lifestyles
Valentini Martina University of Geneva - GE 01.12.2017 31.01.2022 Ambizione

Expression and regulation of the insulin and glucagon genes
Philippe Jacques University of Geneva - GE 01.10.1991 30.09.1996 Project funding (Div. I-III)

Molecular Biology of the Immune Response
Mach Bernard University of Geneva - GE 01.10.1981 31.12.1983 Project funding (Div. I-III)

Need for a better understanding of viral particle assembly to elucidate the mechanisms of negative stranded RNA virus persistance
Roux Laurent University of Geneva - GE 01.04.1991 31.03.1994 Project funding (Div. I-III)

Multidrug efflux systems and virulence factor expression in Pseudomonas aeruginosa
Köhler Thilo University of Geneva - GE 01.04.1999 30.09.2001 Project funding (Div. I-III)

Origins of broad-spectrum beta-lactam resistance: multidimensional dissection of chromosomally encoded metallo-beta-lactamases.
Viollier Patrick University of Geneva - GE 01.01.2021 31.12.2024 Sinergia
-